Hugo Albrecht
0000-0002-3951-1866
Publication & Citation Trends
Publications
0 total
Influence of Lyophilization and Cryoprotection on the Stability and Morphology of Drug-Loaded Poly(ethylene glycol-b-ε-caprolactone) Micelles OA
Cited by 10
Semantic Scholar
An Overview of CDK3 in Cancer: Clinical Significance and Pharmacological Implications.
Cited by 13
Semantic Scholar
Using GPCRs as Molecular Beacons to Target Ovarian Cancer with Nanomedicines OA
Cited by 15
Semantic Scholar
An Orally Bioavailable and Highly Efficacious Inhibitor of CDK9/FLT3 for the Treatment of Acute Myeloid Leukemia OA
Cited by 8
Semantic Scholar
Erratum to "A first-in-class CDK4 inhibitor demonstrates in vitro, ex-vivo and in vivo efficacy against ovarian cancer" [Gynecologic Oncology 159 (2020) 827-838]. OA
Cited by 0
Semantic Scholar
Strategies for the Development of pH-Responsive Synthetic Polypeptides and Polymer-Peptide Hybrids: Recent Advancements OA
Cited by 42
Semantic Scholar
CDK9: A Comprehensive Review of Its Biology, and Its Role as a Potential Target for Anti-Cancer Agents OA
Cited by 117
Semantic Scholar
Pharmaceutical Development of 5-Fluorouracil-Eluting Stents for the Potential Treatment of Gastrointestinal Cancers and Related Obstructions OA
Cited by 10
Semantic Scholar
Research Topics
Cancer-related Molecular Pathways
(11)
Nanoparticle-Based Drug Delivery
(10)
Advanced Breast Cancer Therapies
(10)
PI3K/AKT/mTOR signaling in cancer
(8)
Protein Degradation and Inhibitors
(7)
Affiliations
Commonwealth Scientific and Industrial Research Organisation
University of South Australia
University of California, San Francisco
FHNW University of Applied Sciences and Arts
ETH Zurich